Home  /  Resource Library  /  Matching adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Matching adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Retrospective study compared CAR T therapy lisocabtagene maraleucel with CAR T axicabtagene ciloleucel for treatment of relapsed diffuse large b-cell lymphoma.